Facebook Linkedin RSS Twitter Youtube
Home 2024

Clinical trial

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells
Insights

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells

Biosimilar Manufacturer Focuses on Process Optimization
Bioprocessing

Biosimilar Manufacturer Focuses on Process Optimization

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism
Drug Discovery

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism

Creating Consistency and Confidence for Biopharma Companies
Bioprocessing

Creating Consistency and Confidence for Biopharma Companies

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound
Cancer

Overcoming Drug-Resistant Acute Myeloid Leukemia with Engineered Compound

Potential Sanfilippo Syndrome Treatment, Anakinra, Shows Promise in Clinical Trial
Drug Discovery

Potential Sanfilippo Syndrome Treatment, Anakinra, Shows Promise in Clinical Trial

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show
Cancer

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration
Drug Discovery

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults
Featured

Sex-Specific Parental History of Alzheimer’s Could Identify At-Risk Adults

123...265Page 1 of 265
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.